small molecule

MIPLYFFA

ARIMOCLOMOL CITRATE

Loss of exclusivityNovember 2041latest FDA-listed patent expiry

CompanyZEVRA DENMARK AS

Drug detail

Brand name	MIPLYFFA
Active ingredient	ARIMOCLOMOL CITRATE
Strength	EQ 124MG BASE
Dosage form	CAPSULE
Route	ORAL
Modality	Small molecule
FDA approval	September 2024
Marketing status	RX

Listed patents

Patent	Expires	Type
11707456	November 2041	substance, product
11045460	August 2029	use U-4021
9289472	August 2029	use U-4021
9884058	June 2029	use U-4021

Regulatory exclusivity

Code	Expires
ODE-496	September 2031
NCE	September 2029

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from ZEVRA DENMARK AS